These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Technical bases and regulatory principles]. Bourguet P; Bull Cancer; 2003 Feb; 90 Spec No():S18-22. PubMed ID: 12739333 [No Abstract] [Full Text] [Related]
7. Procedure guideline for tumor imaging using fluorine-18-FDG. Society of Nuclear Medicine. Schelbert HR; Hoh CK; Royal HD; Brown M; Dahlbom MN; Dehdashti F; Wahl RL J Nucl Med; 1998 Jul; 39(7):1302-5. PubMed ID: 9669415 [No Abstract] [Full Text] [Related]
8. Positron-emitting radiopharmaceuticals: how safe are they? Silberstein EB Cancer Biother Radiopharm; 2001 Feb; 16(1):13-5. PubMed ID: 11279793 [No Abstract] [Full Text] [Related]
9. [Metabolic imaging of a malignant myxofibrosarcoma with F-18-FDG and C-11-methionine positron emission tomography]. Weckesser E; Redeker J; Kühnel G; Börner AR; Flügel M; Knapp WH Nuklearmedizin; 2000; 39(3):N38-9. PubMed ID: 10834199 [No Abstract] [Full Text] [Related]
15. Combined FDG and [F-18]fluoride whole-body PET: a feasible two-in-one approach to cancer imaging? Hoegerle S; Juengling F; Otte A; Altehoefer C; Moser EA; Nitzsche EU Radiology; 1998 Oct; 209(1):253-8. PubMed ID: 9769840 [TBL] [Abstract][Full Text] [Related]
16. New approach to clinical evaluation of cancer chemotherapy using positron emission tomography with 18FDG (2-deoxy-2-[18F]fluoro-D-glucose). Takahashi H; Yamaguchi K; Wakui A; Maeda S; Yang PK; Ito M; Matsuzawa T; Fukuda H; Ido T Sci Rep Res Inst Tohoku Univ Med; 1986 Dec; 33(1-4):38-43. PubMed ID: 3498212 [No Abstract] [Full Text] [Related]
17. Increased F-18 fluorodeoxyglucose accumulation in a benign neurofibroma--a pitfall in a patient with thyroid cancer: a case report. Gabriel M; Erler H; Donnemiller E; Riccabona G Nuklearmedizin; 2002 Apr; 41(2):N14-5. PubMed ID: 11989305 [No Abstract] [Full Text] [Related]
19. [Using isotopes with short half-life in the diagnostics of oncological diseases]. Minn H; Kööbi T; Ahonen A Duodecim; 2003; 119(1):26-32. PubMed ID: 12607469 [No Abstract] [Full Text] [Related]
20. Fluorodeoxyglucose positron emission tomography scanning: basic principles and imaging of adult soft-tissue sarcomas. Conrad EU; Morgan HD; Vernon C; Schuetze SM; Eary JF J Bone Joint Surg Am; 2004; 86-A Suppl 2():98-104. PubMed ID: 15691114 [No Abstract] [Full Text] [Related] [Next] [New Search]